Roth Mkm Cuts Celsius (NASDAQ:CELH) Price Target to $43.00

Celsius (NASDAQ:CELH) had its target price cut by Roth Mkm from $45.00 to $43.00 in a research report released on Friday, Benzinga reports. They currently have a buy rating on the stock.

A number of other equities analysts have also recently issued reports on the stock. Maxim Group reduced their price objective on shares of Celsius from $65.00 to $50.00 and set a buy rating on the stock in a research note on Thursday, September 5th. Jefferies Financial Group decreased their price objective on Celsius from $68.00 to $53.00 and set a buy rating for the company in a research note on Thursday, September 5th. Stifel Nicolaus cut their target price on Celsius from $61.00 to $51.00 and set a buy rating on the stock in a research note on Thursday, September 5th. Morgan Stanley restated an equal weight rating and set a $50.00 target price on shares of Celsius in a report on Tuesday, August 20th. Finally, TD Cowen cut their price target on shares of Celsius from $68.00 to $50.00 and set a buy rating on the stock in a research report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of Moderate Buy and a consensus target price of $57.29.

Celsius Stock Performance

Shares of CELH opened at $32.53 on Friday. The firm has a market capitalization of $7.58 billion, a price-to-earnings ratio of 35.75, a PEG ratio of 2.45 and a beta of 1.85. Celsius has a 52 week low of $30.86 and a 52 week high of $99.62. The business’s fifty day moving average price is $38.43 and its two-hundred day moving average price is $61.80.

Celsius (NASDAQ:CELH) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.05. The firm had revenue of $402.00 million during the quarter, compared to analysts’ expectations of $391.07 million. Celsius had a return on equity of 94.75% and a net margin of 19.58%. The company’s quarterly revenue was up 23.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.17 EPS. As a group, research analysts forecast that Celsius will post 0.82 EPS for the current year.

Insider Buying and Selling

In related news, CEO John Fieldly sold 74,847 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the transaction, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Celsius

Large investors have recently bought and sold shares of the company. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Celsius in the second quarter worth $695,000. Newbridge Financial Services Group Inc. boosted its stake in shares of Celsius by 3,150.0% during the 2nd quarter. Newbridge Financial Services Group Inc. now owns 650 shares of the company’s stock worth $37,000 after buying an additional 630 shares during the last quarter. Sanctuary Advisors LLC bought a new position in shares of Celsius in the 2nd quarter valued at about $2,827,000. Clearbridge Investments LLC bought a new position in shares of Celsius in the 2nd quarter valued at about $591,000. Finally, Cetera Investment Advisers increased its position in shares of Celsius by 189.3% in the second quarter. Cetera Investment Advisers now owns 186,476 shares of the company’s stock valued at $10,646,000 after acquiring an additional 122,011 shares during the last quarter. Institutional investors and hedge funds own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.